Han Ying, Li Shiyan, Zhao Bowen, Lv Jianghong, Gao Li
Endocr Connect. 2025 Jun 30;14(6). doi: 10.1530/EC-25-0125. Print 2025 Jun 1.
Information regarding DICER1-related thyroid tumors in children has accumulated; however, the clinical, molecular and radiological characteristics of thyroid nodules with DICER1 mutations in adults are largely unknown, especially those with somatic mutations.
In this study, we sought to find clinical, molecular and radiological characteristics of thyroid diseases with somatic mutations in the DICER1 gene in adults.
Patients (n = 21) aged ≥18 years with somatic DICER1-related thyroid tumors were enrolled.
From 1,289 patients who underwent genotyping for PTC-associated variants, 21 patients with 23 DICER1-related thyroid tumors and confirmed somatic DICER1 variants were selected and analyzed for clinical, molecular and radiographic features.
Somatic DICER1 variants were found in 21 of 1,289 (1.63%) patients with thyroid nodules in this study. All patients were female predominant. Eleven (11/23) were classified as benign and eight (8/23) were malignant, one was a follicular tumor of uncertain malignant potential (FT-UMP) with suspicious capsular invasion and three were under follow-up, in 23 DICER1-related nodules. Eleven nodules (11/23) had other pathogenic gene mutations (RAS and BRAF), and biallelic DICER1 mutations had a high prevalence, about 34.8% (8/23). Ten nodules (10/20) were combined with other tumors with non-DICER1 mutations. No patients had any local invasion or distant metastasis during follow-up. All DICER1-related nodules lacked unique sonographic features, but had the typical appearance of benign or malignant nodules on ultrasound (US).
Somatic DICER1-mutated thyroid nodules in adults usually represent a distinct class of low-risk neoplasms, although they may be accompanied by variants in other thyroid cancer-related genes.
有关儿童DICER1相关甲状腺肿瘤的信息已不断积累;然而,成人中具有DICER1突变的甲状腺结节的临床、分子和放射学特征在很大程度上尚不清楚,尤其是那些具有体细胞突变的结节。
在本研究中,我们试图找出成人中具有DICER1基因体细胞突变的甲状腺疾病的临床、分子和放射学特征。
纳入年龄≥18岁且患有体细胞DICER1相关甲状腺肿瘤的患者(n = 21)。
从1289例接受PTC相关变异基因分型的患者中,选择21例患有23个DICER1相关甲状腺肿瘤且确诊为体细胞DICER1变异的患者,并对其临床、分子和影像学特征进行分析。
在本研究的1289例甲状腺结节患者中,有21例(1.63%)发现体细胞DICER1变异。所有患者均以女性为主。在23个DICER1相关结节中,11个(11/23)被分类为良性,8个(8/23)为恶性,1个为具有可疑包膜侵犯的不确定恶性潜能滤泡性肿瘤(FT-UMP),3个正在随访中。11个结节(11/23)有其他致病基因突变(RAS和BRAF),双等位基因DICER1突变的发生率较高,约为34.8%(8/23)。10个结节(10/20)与其他具有非DICER1突变的肿瘤合并存在。随访期间所有患者均无局部侵犯或远处转移。所有DICER1相关结节均缺乏独特的超声特征,但在超声(US)检查中具有典型的良性或恶性结节表现。
成人中具有体细胞DICER1突变的甲状腺结节通常代表一类独特的低风险肿瘤,尽管它们可能伴有其他甲状腺癌相关基因的变异。